# Why Low NAD+ May Push Insulin-Making Cells Into Self-Inflicted Inflammation

*An epigenetic switch in β-cells links mitochondrial stress to inflammatory fate via HMGB1 acetylation.*

- **Evidence Level**: Preliminary
- **Publication Types**: Journal Article
- **Journal**: Cell death and differentiation
- **Sample Size**: Cell studies plus mouse, pig, and non-human primate models
- **Authors**: Cheng Y, Wang L, Bai X, Zhu G, Xu Y, Wang B, Yi Q, Liao G, Huang J, Wang D, He S
- **Published**: 2026-08-08
- **Topics**: NAD+, NMN, metabolic health
- **DOI**: https://doi.org/10.1038/s41418-026-01839-x
- **Original Source**: https://pubmed.ncbi.nlm.nih.gov/42570950/

## Summary

In cells and animals, oxidative stress drained NAD+ inside the insulin-producing cells of the pancreas, flipping a chemical switch that set off inflammation from within. Topping up NAD+ with NMN calmed that inflammation, and combining it with a second blocker worked better than either alone. The work spanned mice, pigs, and monkeys, so it's mechanism-level research, not a human result. For anyone curious about NAD+ boosters, this hints at why they get studied for metabolic health.

---

_Canonical: https://longevity-austria.com/en/research/why-low-nad-may-push-insulin-making-cells-into-self-inflicted-inflammation · Part of Longevity Cities · Updated 2026-08-08_